"we are progressing towards our goal of MHRA approval for self-test home use. We cannot give a timescale for when this might be achieved but we look forward to updating shareholders on further developments"
Bbi simply jumped the gun that MHRA approval is about to be signed off
They wont need cash for a long time. Think they had around 8 million then they realised another 14 million in april. Plus they had a various Grant's and a loan to expand various things... all in the RNSs going back to april.
Trying to figure out why the SP dropped. All I can come up with is over the past 3 weeks loads of covid stocks in the US dropped together and since Traumakine has been tagged along with the covid shares..? In any case we are spelized for ARDS... unique actually.
Able to test the exact time to delivery interferon beta 1a and paitented to deliver our formulation via IV for the maximum benefit
Any news on Traumakine isn't going to be bad.. I think the covid solution is mudding the waters of what we are about. Plus if other solutions are found that stop covid getting to the stage where Traumakine is need then it looks like we are redundant... But it's not the case. Why cause we were never about covid... We are all about ARDS which a niche market but one where we can help.
As for clevegen! That's the golden goose. But again the world are looking at covid and cancer is not in the spotlight... Even routine cancer checks and ops are put on the back burner while they sit in hospitals waiting for covid paitents.
So I think we will be OK. We have a good future ahead. Just the Fins don't seem to talk much and PR is the one thing faron could do better with!
Noticed for 3 weeks most stocks related to covid have been Going down.. Not sure if it's cause there are too many companies working on some sort of solution.. Or if the covid stock bubble is busting?!?
In any case wondering if the market is confusing us as a covid stock.
When we were accepted in to WHO solidarity Marku said we are not there for a cure for covid. Also with remap it was the same.
Traumakine is about ARDS. Very specific! Something there was no treatment for and as we seem to be seeing when giving at a certain time frame it works well.
The SP seems to be taking a hit but when we get our data then we will have a treatment for a specialised illness.
As for clevegen.. News will be soon after the review of 'the paper' as we have been told and it's good news...